AU6015096A - Antiviral method and antiviral agent - Google Patents

Antiviral method and antiviral agent

Info

Publication number
AU6015096A
AU6015096A AU60150/96A AU6015096A AU6015096A AU 6015096 A AU6015096 A AU 6015096A AU 60150/96 A AU60150/96 A AU 60150/96A AU 6015096 A AU6015096 A AU 6015096A AU 6015096 A AU6015096 A AU 6015096A
Authority
AU
Australia
Prior art keywords
antiviral
agent
antiviral agent
antiviral method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60150/96A
Other languages
English (en)
Inventor
Makoto Kuboki
Masatomo Mori
Takeaki Nagamine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU6015096A publication Critical patent/AU6015096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AU60150/96A 1995-06-12 1996-06-12 Antiviral method and antiviral agent Abandoned AU6015096A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP14486695 1995-06-12
JP31499795 1995-12-04
JP7-314997 1995-12-04
JP7-144866 1995-12-04
JP05178496A JP3837769B2 (ja) 1995-06-12 1996-03-08 抗ウイルス剤
JP8-51784 1996-03-08
PCT/JP1996/001587 WO1996041643A1 (fr) 1995-06-12 1996-06-12 Procede de traitement et agent antiviraux

Publications (1)

Publication Number Publication Date
AU6015096A true AU6015096A (en) 1997-01-09

Family

ID=27294440

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60150/96A Abandoned AU6015096A (en) 1995-06-12 1996-06-12 Antiviral method and antiviral agent

Country Status (3)

Country Link
JP (1) JP3837769B2 (fr)
AU (1) AU6015096A (fr)
WO (1) WO1996041643A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1023901A4 (fr) 1997-10-13 2004-10-27 Otsuka Pharma Co Ltd Produit d'amelioration de l'effet curatif sur l'hepatite c et son application
DE19818842C1 (de) * 1998-04-28 2000-01-05 Suedzucker Ag Erkältungsmittel
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
WO2006033453A1 (fr) * 2004-09-22 2006-03-30 Juntendo Educational Foundation Amplificateur d'activité pour un agent de type interféron
JP2008195690A (ja) * 2007-02-15 2008-08-28 Gunma Univ インターフェロンα／β受容体誘導剤
JP7028401B2 (ja) 2018-02-23 2022-03-02 日清紡ケミカル株式会社 水性カルボジイミド含有液の製造方法
WO2022005848A1 (fr) * 2020-07-01 2022-01-06 Nelson Deanna J Combinaisons de carnosine et de zinc pour le traitement et la prévention d'infections virales

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
TW224053B (fr) * 1991-09-13 1994-05-21 Paul B Chretien
JPH0670070B2 (ja) * 1992-01-14 1994-09-07 財団法人生産開発科学研究所 ２−アミノエタンスルホン酸亜鉛錯体
JP2589245B2 (ja) * 1992-01-14 1997-03-12 財団法人生産開発科学研究所 Ｎ−（３−アルキル（またはアルケニル）−４−ヒドロキシベンゾイル）グリシン亜鉛錯体
JPH0725771B2 (ja) * 1992-06-18 1995-03-22 財団法人生産開発科学研究所 ２−アミノエタンスルホン酸亜鉛錯化合物

Also Published As

Publication number Publication date
JPH09216831A (ja) 1997-08-19
JP3837769B2 (ja) 2006-10-25
WO1996041643A1 (fr) 1996-12-27

Similar Documents

Publication Publication Date Title
AU6136496A (en) Camera and method
AU3673295A (en) Posture change system and posture change method
AU6584296A (en) Well completion system and method
AU4748296A (en) Carrying case and work platform
AU6482298A (en) Voice enhancememt system and method
AU5401896A (en) Electronic competition system and method for using same
IL122428A0 (en) Minizymes and minribozymes and uses thereof
AU7585096A (en) Growth-hormone secretagogues
GB2303996B (en) Communications arrangement and method
AU4139196A (en) Method and composition for antiviral therapy
GB2298713B (en) Method and composition
AU3768095A (en) Herbicidal composition and method
AU6525596A (en) Securement device and method
AU5176396A (en) Graphic transfer and method
AU7969994A (en) Keratorefractive system and method
AU6629496A (en) Antiviral agent and process for preparing the same
EP0836617A4 (fr) Parevines et tachytegrines
AU6135896A (en) Antiviral agents
AU6015096A (en) Antiviral method and antiviral agent
AUPN137895A0 (en) Composition and method
AU7544396A (en) Triazole derivatives and uses thereof
AU3398793A (en) Anti-tumor method and anti-tumor agent
EP0748008A3 (fr) Laser et applications
AU5188296A (en) Carbopeptoids and carbonucleotoids
AU5416996A (en) Dual use vehicle and method